picrosirius red solution (MasterTech Inc)
Structured Review

Picrosirius Red Solution, supplied by MasterTech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/picrosirius+red+solution/med_rxiv__2025__01__12__25320338-239-6-10?v=MasterTech+Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Real-time diagnostics and personalized wound therapy powered by AI and bioelectronics"
Article Title: Real-time diagnostics and personalized wound therapy powered by AI and bioelectronics
Journal: medRxiv
doi: 10.1101/2025.01.12.25320338
Figure Legend Snippet: In Vivo study in porcine model for 22 days. (A) In vivo experiment schedule and setup. (B) photo showing the device was mounted on 20 mm wound of the porcine model. (C) wound stage probability of a treated wound, interpreted by Deep mapper (D) Wound healing progress from control and treated wound, interpreted by Deep mapper. (E) Electric field strength from individual channels of a bioelectronic device. (F) Fluoxetine delivery rate from individual channels of a bioelectronic device. (G) Representative images from the day 22 wounds treated with standard of care (control) or the device. (H) Epidermal thickness was measured on multiple sites across the neo-epithelium covering the two control wounds and one treated wound W6(n control =30, n treated =16, p<0.01) (I) Granulation tissue was identified by difference in histological staining and outlined and area measured. (n= 2, p=0.03) (J) RT-PCR analysis of gene expression from healed wound tissue collected on day 22. Expression of anti-inflammatory IL10 and pro-preparative TGFB1 are elevated in the device treated wounds relative to control standard of care (n=2, IL1b p = 0.10; IL6 p = 0.33; IL10 p = 0.41; IGF1 p = 0.13; TGFb1 p = 0.44; TNF p = 0.57; VEGF p = 0.21). Genes associated with inflammation: IL1B, IL6, and TNFa are reduced in all healed wounds by day 22 (K) Nerve fibers identified by immunohistochemical tagging with antibody to PGP9.5, a protein expressed in peripheral nervous system axons, and imaged using confocal microscopy (Fig. S29) and linear structures within the epidermis tallied. (L) Ratio of collagen type III/I, derived from picrosirius red staining under polarized light from healed wounds at day 22 Fig. S29. (average +/-STDEV, * p<0.05, n=2 wounds)
Techniques Used: In Vivo, Control, Staining, Reverse Transcription Polymerase Chain Reaction, Expressing, Immunohistochemical staining, Confocal Microscopy, Derivative Assay
